McKesson (MCK) Awarded $2.61B U.S. Defense Contract
Get Alerts MCK Hot Sheet
Join SI Premium – FREE
McKesson Corp. (NYSE: MCK) said to have been awarded a U.S. defense contract covering mail order pharmaceutical delivery. The maximum value of the award is $2.61 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Johnson & Johnson's (JNJ) Janssen Receives FDA Approval for Edurant
- Daxor Corp. (DXR) CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
- PureTech Health Plc (PRTC) Announces Proposed $100M Capital Return
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!